1. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA. 2003;289:959–962.
2. Edna TH, Bjerkeset T. Association between blood transfusion and infection in injured patients. J Trauma. 1992;33(5):659–661.
3. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogenic blood transfusion increases the risk of post-operative bacterial infections: a meta analysis. J Trauma. 2003;53(5):908–914.
4. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132(6):620–624.
5. Looney MR, Gropper MA, Matthey MA. Transfusion related acute lung injury: a review. Chest. 2004;126(1):249–258.
6. Blumberg N. Allogenic transfusion and infection: economic and clinical implications. Semin Hematol. 1997;34(3 suppl 2):34–40.
7. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest. 2005;127:295–307.
8. Fergusson D, Khanna MP, Tinmouth A, et al. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Can J Anaesth. 2004;51:417–424.
9. Hebert PC, Tinmouth A, Corwin HL. Controversies in RBC transfusion in the critically ill. Chest. 2007;131: 1583–1590.
10. Corwin HL, AuBuchon JP. Is leukoreduction of blood components for everyone? JAMA. 2003;289:1993–1995.
11. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red cell transfusion: when is it not safe? Crit Care Med. 2003;31:S687–S697.
12. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on
oxygen delivery in patients with sepsis.
JAMA. 1993;269:3024–3029.
13. Fitzgerald RD, Martin CM, Dietz GE, et al. Transfusion red blood cells stored in citrate phosphate
dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats.
Crit Care Med. 1997;25:726–732.
14. Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfus Med Rev. 2001;15: 91–107.
15. Lelubre C, Piagnerelli, M, Vincent JL. Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: myth or reality? Transfusion. 2009;49:1384–1394.
16. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill—current clinical practice in the United States. Crit Care Med. 2004;32:39–52.
17. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288: 1499–1507.
18. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409–417.
19. Wen-Chih W, Saif SR, Yongfei W, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345(17):1230–1236.
20. Hebert PC, Tinmouth A, Corwin H. Anemia and red cell transfusion in critically ill patients. Crit Care Med. 2003;31(12 suppl):S672–S677.
21. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858–873.
22. Rivers E, Nguyen B, Havstad S, et al, Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377.
23. McIntyre L, Hebert PC, Wells G, et al, Canadian Critical Care Trials Group. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma. 2004;57(3):563–568.
24. Malone DL, Dunne J, Tracey JK, et al. Blood transfusion, independent of shock severity is associated with worse outcome in trauma. J Trauma. 2003;54(5):898–905.
25. Carlson AP, Schermer CR, Lu SW. Retrospective evaluation of anemia and transfusion in traumatic brain injury. J Trauma. 2006;61:567–571.
26. Napolitano LM, Kurek S, Luchette FA, et al, American College of Critical Care Medicine of the Society of Critical Care Medicine, Eastern Association for the Surgery of Trauma Practice Management Workgroup. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37:3124–3157.
27. Consensus conference. Fresh-frozen plasma. Indications and risks. JAMA. 1985;253:551–553.
28. McVay PA, Toy PTCY. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;21:164–171.
29. Shanberge JN, Quattrochiocchi-Longe T. Analysis of fresh frozen plasma administration with suggestions for ways to reduce usage. Transfus Med. 1992;2:189–194.
30. Gajic O, Dzik WH, Toy P. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm? Crit Care Med. 2006;34 (5 suppl):S170–S173.
31. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA. 1994;271:777–781.
32. Ansell, J, Hirsh, J, Hylek, E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:160S.
33. Stanworth SJ, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004;126(1):139–152.
34. Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol. 2006;126(1): 133–139.
35. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006;46(8):1279–1285.
36. Doerfler ME, Kaufman B, Goldenberg AS. Central venous catheter placement in patients with disorders of hemostasis. Chest. 1996;110:185–188.
37. Cotton BA, Au BK, Nunez
TC, et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications.
J Trauma. 2009;66(1):41–48.
38. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcomes in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248(3):447–458.
39. Zink KA, Sambasivan CN, Holcomb JB, et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg. 2009;197(5): 565–570.
40. Snyder CW, Weinberg JA, McGwin G, et al. The relationship of blood product ratio to mortality: survival benefit or bias? J Trauma. 2009;66:358–364.
41. Slichter SJ. Controversies in platelet transfusion therapy. Annu Rev Med. 1980;31:509–540.
42. NIH Consensus Conference. Platelet transfusion therapy. JAMA. 1987;257:1777–1780.
43. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122:10.
44. Beutler E. Platelet transfusion: the 20,000/ul trigger. Blood. 1993;81:1411–1413.
45. Heckman K, Weiner GJ, Strauss RG, et al. Randomized evaluation of the optimal platelet count for prophylactic platelet transfusion in patients undergoing induction therapy for acute leukemia. Blood. 1993;82(S1):192a.
46. Harkness DR, Byrnes JJ, Lian EC-Y, et al. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA. 1981;246:1931.
47. Warkentin TE, Greinacher A, Koster A, et al. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:340S.
48. Eschbach JW, Egrie IC, Downing MR, et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med. 1987;316:73–79.
49. Rogiers P, Zhang H, Leeman M, et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med. 1997;23(2):159–162.
50. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288(22):2827–2835.
51. Corwin HL, Gettinger A, Fabian
TC, et al. Efficacy and safety of epoetin alfa in critically ill patients.
N Engl J Med. 2007 6;357(10):965–976.
52. Napolitano LM, Fabian
TC, Kelly KM, et al. Improved survival of critically ill trauma patients treated with recombinant human erythropoietin.
J Trauma. 2008;65(2):285–297.